Elevated HDL levels linked to poorer cognitive ability in females with Parkinson's disease
Publication Details
Bakeberg, M. C.,
Gorecki, A. M.,
Kenna, J. E.,
Jefferson, A.,
Byrnes, M.,
Ghosh, S.,
Horne, M. K.,
McGregor, S.,
Stell, R.,
Walters, S.,
Mastaglia, F. L.,
&
Anderton, R. S.
(2021).
Elevated HDL levels linked to poorer cognitive ability in females with Parkinson's disease.
Frontiers in Aging Neuroscience, 13.
Abstract
Introduction: Cholesterol levels have been associated with age-related cognitive decline, however, such an association has not been comprehensively explored in people with Parkinson’s disease (PD). To address this uncertainty, the current cross-sectional study examined the cholesterol profile and cognitive performance in a cohort of PD patients.
Methods: Cognitive function was evaluated using two validated assessments (ACER and SCOPA-COG) in 182 people with PD from the Australian Parkinson’s Disease Registry. Total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and Triglyceride (TRG) levels were examined within this cohort. The influence of individual lipid subfractions on domain-specific cognitive performance was investigated using covariate-adjusted generalised linear models.
Results: Females with PD exhibited significantly higher lipid subfraction levels (TC, HDL, and LDL) when compared to male counterparts. While accounting for covariates, HDL levels were strongly associated with poorer performance across multiple cognitive domains in females but not males. Conversely, TC and LDL levels were not associated with cognitive status in people with PD.
Conclusion: Higher serum HDL associates with poorer cognitive function in females with PD and presents a sex-specific biomarker for cognitive impairment in PD.
Keywords
Parkinson’s disease, cognitive decline, cognitive impairment, domain-specific, cholesterol, HDLcholesterol, sex-specific
Link to Publisher Version (URL)
